Dana Small, a neurology and neurosurgery professor at McGill University, said GLP-1 drugs are not a magic bullet. It is absolutely the case that when you lose weight, you lose fat mass, but also lean mass, muscle mass
However, some reports of severe gastrointestinal events and other health problems were not included on the warning label
Cochr Datab Syst Rev
Any stacking approach requires understanding the interactions, timing, and dosing adjustments for each compound
a Clinicaltrials.gov identifier ( Table 2 Summary of Clinical Trials in Which the Cardiovascular Effects of GLP-1 RAs Were Non-Primary Outcomes GLP-1 RA, glucagon-like peptide-1 receptor agonist
In these individuals the most common manifesting symptoms are leukoencephalopathy and peripheral neuropathy